Inhibikase Therapeutics | 8-K: Current report
Apr 30 20:20
Inhibikase Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Apr 30 04:41
Inhibikase Therapeutics | DEFA14A: Others
Apr 27 04:38
Inhibikase Therapeutics | DEF 14A: Definitive information statements
Apr 27 04:21
Inhibikase Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Apr 26 04:31
Inhibikase Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933
Apr 20 05:15
Inhibikase Therapeutics | 8-K: Current report
Apr 19 18:11
Inhibikase Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Apr 16 04:14
Inhibikase Therapeutics | 8-K/A: Current report (Amendment)
Apr 3 05:17
Inhibikase Therapeutics | 8-K: Current report
Feb 7 21:01
Inhibikase Therapeutics | 8-K: Current report
Feb 2 05:14
Inhibikase Therapeutics | 8-K: Current report
Jan 16 13:00
Inhibikase Therapeutics | 8-K: Current report
Sep 20, 2023 23:23
Inhibikase Therapeutics | 8-K: Current report
Jul 18, 2023 05:29
Inhibikase Therapeutics | 8-K: Current report
Jun 30, 2023 00:15
Inhibikase Therapeutics | 8-K: Current report
Jun 28, 2023 19:08
Inhibikase Therapeutics | DEFA14A: Others
May 13, 2023 04:16
Inhibikase Therapeutics | DEF 14A: Definitive proxy statements
May 6, 2023 04:31
Inhibikase Therapeutics | PRE 14A: Preliminary proxy statement not related to a contested matter or merger/acquisition
Apr 22, 2023 04:30
Inhibikase Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Apr 1, 2023 04:11
No Data
No Data